期刊文献+

FDA药品安全监管体系的改革调整及启示 被引量:3

Reform Measures and Suggestion of the Drug Safety Supervision System of FDA
下载PDF
导出
摘要 目的介绍FDA药品安全监管体系的改革措施。方法通过对FDA药品安全监管体系多方面的文献研究,介绍其体系的改革措施及美国政府问责办公室和美国医学会对该体系的评价报告。结果与结论对该体系组织机构的调整进行总结,研究其对我国的启示。 Objective To introduce the reform measures of the drug safety supervision system of FDA. Methods To research the drug safety supervision system of FDA in several ways, introduced the reform measures implemented by FDA and the evaluation reports from GAO and IOM. Results and Conclusions summarized organizations' restructuring of FDA.
出处 《中国药事》 CAS 2009年第6期609-611,共3页 Chinese Pharmaceutical Affairs
关键词 FDA 药品安全 监管体系 改革 FDA safety of drug regulatory system reform
  • 相关文献

参考文献7

  • 1Paul J. Seligman. Assessing the Safety of Marketed Drugs [EB/OL] . [2007-12-24] . FDA Regulatory & Compliance Symposium Cambridge, MA.
  • 2GAO (Government Accountability Office) .Drug Safety Improvement Needed in FDA's Postmarket Dedsion-marketing and Oversight Process [EB/OL] . [2007-12-13] . http: // www. gao. gov/new, items/dob402, pdf.
  • 3IOM (Institute of Medicine) . The Future of Drug Safety : Promoting and Protecting the Health of the Public[EB/OL] . [2007-09-22] . http.. //www. iom. edu/? id= 37337.
  • 4FDA. Center for Drug Evaluation and Research (CDER) Organization Charts and Directories [EB/OL] . [2007-12- 06] . http: //www. fda. gov/cder/cderorg, html.
  • 5FDA. Manual of Policies and Procedures [EB/OL] . [2007- 12-18] . http: //www. fda. gov/cder/mapp/4151,3R. pdf.
  • 6FDA. Office of Surveillance and Epidemiology (OSE) [EB/ OL] . [2007-12-18] . http: //www. fda. gov/cder/Offices/ ODS/default. htm.
  • 7FDA. [EB/OL] . [2007-12-18] . http: //www. fda. gov/ cder/cderorg/spcs, html.

同被引文献26

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部